The estimated lifetime probability of acquiring human papillomavirus in the United States.
Harrell W Chesson, Eileen F Dunne, Susan Hariri...
https://pubmed.ncbi.nlm.nih.gov/25299412/Actively Recruiting
Led by Peking University People's Hospital · Updated on 2024-11-05
150
Participants Needed
2
Research Sites
4 weeks
Total Duration
Human papillomavirus HPV infection is a common viral infection of the genital tract mainly spread through sexual contact, with an estimated 85% to 90% lifetime infection risk among sexually active individuals. While much research has focused on HPV in women, studies on male HPV infections are limited. Many men carry HPV without symptoms, which complicates prevention and control efforts. This study aims to develop and evaluate a reliable method for detecting HPV in men using self-collected urine samples, which could offer a less invasive and more convenient alternative to traditional penile swab tests. The study consists of two parts. The first part compares HPV detection results from self-collected urine samples with those from physician-collected penile samples in male patients with genital warts, penile intraepithelial neoplasia PIN, and penile cancer. The second part investigates HPV consistency between urine samples from male patients and their female partners by comparing male urine and penile samples with cervical swabs from female partners. Participants provide self-collected urine samples followed by physician-collected samples for comparison. Participants will provide urine and swab samples, and data will be collected to compare HPV detection accuracy between self-collected urine and physician-collected genital samples, as well as between couples. The main outcome is to evaluate the test results of the new HPV detection method on urine samples compared to standard genital sample tests within a 12-week period. Secondary outcomes include assessing the consistency of HPV presence in couples within 8 weeks. This research may provide new strategies for male-specific HPV detection using home-based self-testing methods.
CONDITIONS
Clinical Performance of Urine HPV Testing in Males
Y
Yongping Zhao, Chief physician
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Peking University People's Hospital
Lead Sponsor
Hangzhou Newhorizon Health Technology Co., Ltd.
Collaborating Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Up to 12 weeks
Participants collect urine samples themselves, followed by physicians collecting additional urine and genital samples for HPV testing to compare consistency between sample types and between partners.
1 to 2 visits depending on sample collection and partner involvement
Duration - Up to 8 weeks
Participants are observed for consistency of HPV nucleic acid results between male and female partners using urine samples to explore joint testing feasibility.
Follow-up visits as needed during observation period
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Have more questions? Get in touch with our team for quick support
Harrell W Chesson, Eileen F Dunne, Susan Hariri...
https://pubmed.ncbi.nlm.nih.gov/25299412/Paul H M Smits, Remco Bakker, Eefje Jong...
https://pubmed.ncbi.nlm.nih.gov/16333078/Suzanne M Garland, Susanne K Kjaer, Nubia Muñoz...
https://pubmed.ncbi.nlm.nih.gov/27230391/Huamei Wu, Xichen Tong, Lei Wang...
https://pubmed.ncbi.nlm.nih.gov/37389484/Peking University People's Hospital
Lead Sponsor
Hangzhou Newhorizon Health Technology Co., Ltd.
Collaborating Sponsor